The DI represents the product of measures of insulin sensitivity and the acute insulin response to glucose (AIRg, an index of first-phase insulin secretion), thus expressing the ability of β-cells to compensate for augmented insulin resistance with changes in the first-phase secretion [44]. The gene discussed is INS; the disease is Insulin resistance.